introduction: vitiligo is a cutaneous disorder of pigmentation, for which, there are some proven modalities of treatment. in this study, we evaluated the efficacy of the addition of topical pimecrolimus to 308nm excimer laser in reducing treatment duration and improving the response rate of eyelid vitiligo, compared with 308nm excimer laser monotherapy. methods: fifty two symmetrically localize...

,, background, medical treatment+ NB-UVB phototherapy is a very important modality in treating vitiligo but the treatment course usually exceeds 1 year. Different corrective surgical methods have evolved during the last four decades. various techniques of vitiligo surgery have been improvised and modified to achieve better results Some of these are: mini punch grafting,basal cell layer suspensi...

TACROLIMUS OINTMENT VERSUS PIMECROLIMUS CREAM IN PATIENTS WITH ATOPIC DERMATITIS INVOLVING THE HEAD AND/OR NECK Robert Kirsner, MD, PhD, University of Miami School of Medicine, Miami, FL, United States; Richard Antaya, MD, Yale University School of Medicine, New Haven, CT, United States; Alan B. Fleischer, Jr, MD, Wake Forest University School of Medicine, Winston-Salem, NC, United States; Rich...

Atopic dermatitis (AD) is a chronic and relapsing, inflammatory skin disease characterized by impaired barrier function immune system dysregulation that results in dryness, microbiome dysbiosis intense pruritus. It highly heterogeneous, its management demanding. Patients with AD are at greater risk of comorbidities such as attention-deficit hyperactivity disorder well other atopic diseases. Ear...

Abstract: Background: Atopic dermatitis, is a multifactorial chronic inflammatory and immunological disease affecting the skin, with serious impact on psychological life style of patients. Unique polyherbal combination Aloe vera, Erngium foetidum, Passiflora edulis, Syzygium samarangense, based established profile relevant to anti-inflammatory, immunomodulatory anti-oxidant property formulated ...

Topical steroids are used for the treatment of primary atopic dermatitis (AD); however, their associated risk of serious complications is great due to the presence of vulnerable lesions in young children with AD. Topical calcineurin inhibitors (TCIs) are steroid-free, anti-inflammatory agents used for topical AD therapy. However, their use is prohibited in infants <2 years of age because of the...